Plasma-surface modification (PSM) is an effective and economical surface treatment technique for many materials and of growing interests in biomedical engineering. This article reviews the various common plasma techniques and experimental methods as applied to biomedical materials research, such as plasma sputtering and etching, plasma implantation, plasma deposition, plasma polymerization, laser plasma deposition, plasma spraying, and so on. The unique advantage of plasma modification is that the surface properties and biocompatibility can be enhanced selectively while the bulk attributes of the materials remain unchanged. Existing materials can, thus, be used and needs for new classes of materials may be obviated thereby shortening the time to develop novel and better biomedical devices. Recent work has spurred a number of very interesting applications in the biomedical field. This review article concentrates upon the current status of these techniques, new applications, and achievements pertaining to biomedical materials research. Examples described include hard tissue replacements, blood contacting prostheses, ophthalmic devices, and other products. #

Surface-adherent polydopamine (PDA) films as multifunctional coatings can be easily deposited onto a wide range of materials through dopamine self-polymerization. However, a lack of in-depth understanding of PDA aggregation and deposition processes and definite structure elucidation of PDA make it challenging to tailor the surface characteristic and functionality of the PDA films. Herein, we demonstrate that the surface characteristics of the PDA films can be readily tuned by controlling the competitive interplay between PDA aggregation in solution and deposition on the substrate. Moreover, a structural investigation of the PDA films using analytical tools such as X-ray photoelectron spectroscopy (XPS), time-of-flight secondary ion mass spectrometry (ToF-SIMS), and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) allows us to propose a new structure model for the PDA building block. The (DHI)2/PCA trimer complex, which consists of two 5,6-dihydroxyindole (DHI) units and one pyrrolecarboxylic acid (PCA) moiety, is definitely identified as a primary building block of PDA, and its formation is steered by covalent interactions in the initial stages of polymerization. In latter stages, the (DHI)2/PCA trimer complexes are further linked primarily through noncovalent interactions to build up the supramolecular structure of PDA. This study provides new insights into the mechanisms of PDA buildup.

No abstract

No abstract